Ovarian Cancer Clinical Trials in Philadelphia

Showing 261-264 of 264 trials

ABT-751 in Treating Young Patients With Refractory Solid Tumors

NCT00036959

RATIONALE: Drugs used in chemotherapy, such as ABT-751, work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase I trial is studying the side effects of ABT-751 in treating young patients with refractory solid tumors.

Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more

National Institutes of Health Clinical Center (CC)90 participantsStarted Mar 2002

Chicago, Illinois, United States • Bethesda, Maryland, United States • Philadelphia, Pennsylvania, United States

UNKNOWNNA< 1 mile

Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass

NCT00238342

RATIONALE: Finding specific proteins in the blood may help doctors tell whether a patient has ovarian cancer. PURPOSE: This clinical trial is studying how well proteomic profiling works in diagnosing ovarian cancer in patients who are undergoing surgery for an abnormal pelvic mass.

Fallopian Tube CancerOvarian Cancer

Gynecologic Oncology Group2,000 participantsStarted Oct 2005

Birmingham, Alabama, United States • Fayetteville, Arkansas, United States • Fayetteville, Arkansas, United States +104 more locations

ABT-751 in Treating Young Patients With Refractory Solid Tumors

Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass

Ovarian Cancer Trials in Other Cities

Clinical Trial for Ovarian Cancer (OvaRex®)

Study of XL999 in Patients With Previously Treated Ovarian Cancer

Other Conditions in Philadelphia